Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
07 févr. 2024 08h00 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to...
Global Ophthalmology Market Poised for Robust Growth: Comprehensive Research Forecast 2023-2030 Highlights Disease, Product, and End-User Segments
07 févr. 2024 04h30 HE
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses...
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
06 févr. 2024 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
01 févr. 2024 01h03 HE
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
Global Macular Degeneration Treatment Market Forecast to 2031: Breakthrough in Durable Anti-VEGF Drugs Redefines Patient Care with Less Frequent Dosing
26 janv. 2024 06h27 HE
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Retinal Biologics Global Market Report 2023: Innovations Key to Future Advances - Long-term Forecasts to 2028 and 2033
25 janv. 2024 09h33 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Retinal Biologics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. Profound analytics indicate that the...
Vitrectomy Devices Market Forecast to Surge at Rapid Pace Due to Rising Retinal Disorders and Technological Innovations by 2028
25 janv. 2024 05h19 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Vitrectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. ...
Retinopathy of Prematurity Research Reveals Market Insights, Epidemiology, and Forecast to 2032
24 janv. 2024 10h49 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Retinopathy of Prematurity - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Global Smart Contact Lenses Market by Lens Designs, Materials, Application, Distribution Channel, End-User - Forecast 2024-2030
24 janv. 2024 08h52 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Smart Contact Lenses Market by Lens Designs, Materials, Application, Distribution Channel, End-User - Forecast 2024-2030" report has been added...
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis Report and Segment Forecast 2024-2030 - A $781.2 Million Market by 2030, Registering a CAGR of 5.36%
24 janv. 2024 05h34 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Trends Analysis Report by Product (Valves, Glaucoma Drainage...